Navigation Links
Boston Scientific to Participate in Morgan Stanley Conference
Date:4/24/2008

NATICK, Mass., April 24 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Morgan Stanley Global Healthcare Unplugged Conference, which is being held April 30 - May 2 in Miami.

On Wednesday, April 30, at 9:50 a.m. ET, Paul LaViolette, Chief Operating Officer of Boston Scientific, will present a five-minute overview of the Company, followed by a 35-minute question and answer session.

A live webcast of Mr. LaViolette's remarks will be available to all interested parties at Boston Scientific's website at http://www.bostonscientific.com. To ensure a timely connection to the webcast it is recommended that users register at least 15 minutes before the webcast begins.

This webcast is being hosted by Morgan Stanley. The replay will be archived and available in the Investor Relations site at http://www.bostonscientific.com.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

CONTACT: Larry Neumann

508-650-8696

Investor Relations

Boston Scientific Corporation

Paul Donovan

508-650-8541

Media Relations

Boston Scientific Corporation


'/>"/>
SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Boston Scientific Completes Enrollment in Landmark Heart Failure Trial
2. Boston Scientific Named Healthcare Supplier of the Year by Global Healthcare Exchange (GHX)
3. Philips Supports the Boston Marathon as the Sole Provider of Life-Saving Medical Devices
4. DARA Announces Surgi-Vision Agreement with Boston Scientific Corporation
5. Boston Trial to Test New HIV/AIDS Vaccine
6. Boston College biologists build a better mouse model for cancer research
7. Every Boston Red Sox Home Run Televised on NESN in 2008 to Help Children With Medical Needs
8. Boston Scientific Announces Appointment of Timothy Pratt as General Counsel
9. Boston Kids Enjoy Free Davis Vision Screenings
10. Boston Medical Center Meets Prescription Challenges With Kryptiq ePrescribing Solution
11. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: